ALB vs LIVN · rev $1.74B vs P/E 41, rev $752.8M
Albemarle Corp (ALB) versus LivaNova PLC (LIVN) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
LivaNova PLC (LIVN) is a medical devices company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported LIVN revenue for 2026-06-30 was $752.8M. Net income was $130.9M. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
ALB currently screens at market cap $8.00B. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
Not investment advice. Open the ALB and LIVN stock pages for the full models.
Not investment advice.